Impact of medication reconciliation for improving transitions of care

Redmond, Patrick; Grimes, Tamasine; McDonnell, Ronan; Boland, Fiona; Hughes, Carmel; Fahey, Tom

doi:10.1002/14651858.cd010791.pub2

Cited by 120 publications

(149 citation statements)

References 57 publications

Supporting

Mentioning

144

Contrasting

Unclassified

Order By: Relevance

“…It is anticipated from our identified rate of error/harm that the cost of "no action taken" is high in terms of a patient's subsequent use of the healthcare services post-hospital discharge. A number of reviews have been published that evaluated interventions (including medication reconciliation, community pharmacy involvement and electronic communication interventions) to reduce MEs and ADEs post-discharge [140][141][142][143][144][145][146]. However, none have reported consistent reductions in these outcomes.…”

Section: Implications Of Findingsmentioning

confidence: 99%

Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review

2020

View full text Add to dashboard Cite

Background Little is known about the epidemiology of medication errors and medication-related harm following transition from secondary to primary care. This systematic review aims to identify and critically evaluate the available evidence on the prevalence and nature of medication errors and medication-related harm following hospital discharge. Methods Studies published between January 1990 and March 2019 were searched across ten electronic databases and the grey literature. No restrictions were applied with publication language or patient population studied. Studies were included if they contained data concerning the rate of medication errors, unintentional medication discrepancies, or adverse drug events. Two authors independently extracted study data. Results Fifty-four studies were included, most of which were rated as moderate (39/54) or high (7/54) quality. For adult patients, the median rate of medication errors and unintentional medication discrepancies following discharge was 53% [interquartile range 33-60.5] (n = 5 studies) and 50% [interquartile range 39-76] (n = 11), respectively. Five studies reported adverse drug reaction rates with a median of 27% [interquartile range 18-40.5] and seven studies reported adverse drug event rates with a median of 19% [interquartile range 16-24]. For paediatric patients, one study reported a medication error rate of 66.3% and another an adverse drug event rate of 9%. Almost a quarter of studies (13/54, 24%) utilised a follow-up period post-discharge of 1 month (range 2-180 days). Drug classes most commonly implicated with adverse drug events were antibiotics, antidiabetics, analgesics and cardiovascular drugs. Conclusions This is the first systematic review to explore the prevalence and nature of medication errors and adverse drug events following hospital discharge. Targets for future work have been identified.

show abstract

Section: Implications Of Findingsmentioning

confidence: 99%

Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review

2020

View full text Add to dashboard Cite

show abstract

“…The literature contains many published examples of pharmacist impact during TOC; however, this article does not represent an exhaustive review of the literature. (For a more complete review of the available evidence, see recent systematic reviews on this topic …”

Section: Introductionmentioning

confidence: 99%

“…8 For the present paper, members of the 2019 ACCP Clinical the available evidence, see recent systematic reviews on this topic. [9][10][11][12] ) Rather, this article reviews representative evidence that highlights important, high-impact features of the roles of clinical pharmacists and other pharmacy support personnel in improving TOC, with particular attention given to their roles in reducing readmissions and improving medication safety. This article is designed to be a practical guide for practicing pharmacists to identify current and emerging strategies to optimize TOC.…”

Section: Introductionmentioning

confidence: 99%

Role of clinical pharmacists and pharmacy support personnel in transitions of care

Stranges

Jackevicius

Anderson

et al. 2020

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Patients moving between health care settings or providers are at increased risk of complications, including unplanned hospital readmissions and medication errors. Several actions must occur in concert with members of the health care team and across settings to ensure coordinated and continuous care for patients undergoing these transitions of care (TOC). Clinical pharmacists support patients during care transitions by providing interventions and services designed to improve medication outcomes. Clinical pharmacists and team members who support clinical pharmacist activities (eg, pharmacy students, technicians, and residents) are located throughout the care continuum, from acute care to care in the community, with each contributing to improved TOC outcomes. This article provides information on evidence of high‐impact clinical pharmacist TOC practices to serve as a practical guide for practitioners interested in starting or improving TOC activities. This article also addresses current and emerging best practices and offers suggestions for improving clinical pharmacist involvement in care transition activities.

show abstract

“…7,8 However, medication reconciliation has not been shown to reduce ADEs or prevent readmissions after transitions of care. 9 MTM, while more comprehensive than medication reconciliation, has also not been shown reduce ADEs or improve overall mortality. 10 In studies of these and other types of medication reviews, researchers find that deprescribing is uncommon, and patients are often put on more medications, not fewer, after the review.…”

mentioning

confidence: 98%

“…There is some evidence to show that pharmacist‐led reviews of patients' medications help reduce medication discrepancies and improve adherence . However, medication reconciliation has not been shown to reduce ADEs or prevent readmissions after transitions of care . MTM, while more comprehensive than medication reconciliation, has also not been shown reduce ADEs or improve overall mortality .…”

mentioning

confidence: 99%